Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases

被引：20
|
作者：
Papamichael, Konstantinos [1 ]
Clarke, William T. [1 ]
Vande Casteele, Niels [2 ]
Germansky, Katharine A. [1 ]
Feuerstein, Joseph D. [1 ]
Melmed, Gil Y. [3 ]
Siegel, Corey A. [4 ]
Irving, Peter M. [5 ]
Cheifetz, Adam S. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[3] Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA
[4] Dartmouth Hitchcock Med Ctr, Dept Gastroenterol & Hepatol, Lebanon, NH 03766 USA
[5] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol & Hepatol, London, England
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2021年 / 19卷 / 04期
关键词：
D O I：
10.1016/j.cgh.2020.03.002
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：839 / +
页数：5
相关论文
共 50 条
  • [1] METHOD COMPARISON STUDY OF ASSAYS FOR THE DETERMINATION OF INFLIXIMAB, ADALIMUMAB, AND ANTI-DRUG ANTIBODY LEVELS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Nagore, D.
    Ruiz del Agua, A.
    Pascual, J.
    Llinares-Tello, F.
    Herreros, B.
    Martinez, A.
    Martin, S.
    Navarro, R.
    del Rio, L.
    GUT, 2015, 64 : A99 - A100
  • [2] New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases
    Nemoz, Benjamin
    Ternant, David
    Bailly, Sebastien
    Gautier-Veyret, Elodie
    Jourdil, Jean-Francois
    Bonaz, Bruno
    Stanke-Labesque, Francoise
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (04) : 722 - 728
  • [3] Review article: determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease
    Gibson, David J.
    Ward, Mark G.
    Rentsch, Clarissa
    Friedman, Antony B.
    Taylor, Kirstin M.
    Sparrow, Miles P.
    Gibson, Peter R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (06) : 612 - 628
  • [4] Therapeutic Drug Monitoring of Adalimumab in Patients With Inflammatory Bowel Disease
    El-Matary, Wael
    CROHNS & COLITIS 360, 2019, 1 (03)
  • [5] THERAPEUTIC CUT-OFF OF INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Nagore, D.
    Ruiz del Agua, A.
    Pascual, J.
    Llinares-Tello, F.
    Herreros, B.
    Martinez, A.
    Martin, S.
    Navarro, R.
    GUT, 2015, 64 : A99 - A99
  • [6] Infliximab desensitization in patients with Inflammatory Bowel Diseases: a safe therapeutic alternative
    Hammoudi, N.
    Hassid, D.
    Bonnet, J.
    Minh, M. L. Tran
    Baudry, C.
    Chedouba, L.
    Vauthier, A.
    Gornet, J. M.
    Allez, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 643 - 643
  • [7] Therapeutic Cut- Off of Infliximab in Patients With Inflammatory Bowel Diseases
    Nagore, Daniel
    del Agua, Ainhoa Ruiz
    Pascual, Javier
    Llinares-Tello, Francisca
    Herreros, Belen
    Martinez, Antonio
    GASTROENTEROLOGY, 2015, 148 (04) : S860 - S860
  • [8] Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative
    Hammoudi, Nassim
    Hassid, Deborah
    Bonnet, Joelle
    Tran Minh, My-Linh
    Baudry, Clotilde
    Vauthier, Anne
    Chedouba, Leila
    Houze, Pascal
    Lourenco, Nelson
    Aparicio, Thomas
    Gornet, Jean-Marc
    Allez, Matthieu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (05) : 553 - 560
  • [9] Therapeutic drug monitoring of infliximab and adalimumab versus clinical control during maintenance therapy in patients with Inflammatory Bowel Disease
    Munoz Villafranca, M. D. C.
    Merino, O.
    Gomez, L.
    Higuera, R. O.
    Arreba, P.
    Nagore, D.
    Ruiz-Arguello, B.
    Gorostiza, I.
    Lopez, M. L.
    Ortiz de Zarate, J.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1570 - I1570
  • [10] The use of therapeutic drug monitoring for infliximab and adalimumab in inflammatory bowel disease: Practice patterns, understanding and interpretation
    Samaan, M. A.
    Irving, P. M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S376 - S377
12345